Other

Dataset Information

0

CRISPR GENome and Epigenome Engineering (CRISPRgenee) improves loss-of-function genetic screening approaches


ABSTRACT: The CRISPR/Cas9 technology has revolutionized genotype-to-phenotype assignments through large-scale loss-of-function (LOF) screens. However, limitations like editing inefficiencies and unperturbed genes cause significant noise in data collection. To address this, we introduce CRISPR Gene and Epigenome Engineering (CRISPRgenee), which uses two specific sgRNAs to simultaneously repress and cleave the target gene within the same cell, increasing LOF efficiencies and reproducibility. CRISPRgenee outperforms conventional CRISPRko, CRISPRi, or CRISPRoff systems in suppressing challenging targets and regulators of cell proliferation. Additionally, it efficiently suppresses modulators of epithelial-to-mesenchymal transition (EMT) and impairs neuronal differentiation in a human induced pluripotent stem cell (iPSC) model. CRISPRgenee exhibits improved depletion efficiency, reduced sgRNA performance variance, and accelerated gene depletion compared to individual CRISPRi or CRISPRko screens, ensuring consistency in phenotypic effects and identifying more significant gene hits. By combining CRISPRko and CRISPRi, CRISPRgenee increases LOF rates without increasing genotoxic stress, facilitating library size reduction for advanced LOF screens.

ORGANISM(S): synthetic construct Homo sapiens

PROVIDER: GSE238225 | GEO | 2025/05/05

REPOSITORIES: GEO

Dataset's files

Source:
Action DRS
Other
Items per page:
1 - 1 of 1

Similar Datasets

2023-08-31 | GSE241933 | GEO
2021-11-10 | PXD019350 | Pride
2024-10-08 | GSE272457 | GEO
2024-10-08 | GSE272454 | GEO
2023-12-19 | GSE196911 | GEO
2022-06-30 | E-MTAB-8027 | biostudies-arrayexpress
2021-04-12 | GSE168012 | GEO
2017-05-31 | E-MTAB-5308 | biostudies-arrayexpress
2017-03-03 | GSE89763 | GEO
2022-06-03 | GSE205147 | GEO